Short-term diabetes attenuates left ventricular dysfunction and mortality rates after myocardial infarction in rodents by Rodrigues, Bruno et al.
BASIC RESEARCH
Short-term diabetes attenuates left ventricular
dysfunction and mortality rates after myocardial
infarction in rodents
Bruno Rodrigues,I,II Diego Mendrot Taboas Figueroa,II Jiao Fang,II Kaleizu Teodoro Rosa,II Suzana Llesuy,III
Ka´tia De Angelis,IV Maria Cla´udia IrigoyenII
IHuman Movement Laboratory, Sa˜o Judas Tadeu University, Sa˜o Paulo/SP, Brazil. IIHypertension Unit, Heart Institute (InCor), Medical School of University
of Sa˜o Paulo, Sa˜o Paulo/SP, Brazil. IIICa´tedra de Quı´mica General y Inorga´nica, Facultad de Farma´cia y Bioquı´mica, Universidad de Buenos Aires, Buenos
Aires, Argentina. IVNove de Julho University, Sa˜o Paulo/SP, Brazil.
OBJECTIVES: To investigate the effects of hyperglycemia on left ventricular dysfunction, morphometry, myocardial
infarction area, hemodynamic parameters, oxidative stress profile, and mortality rate in rats that had undergone
seven days of myocardial infarction.
INTRODUCTION: Previous research has demonstrated that hyperglycemia may protect the heart against ischemic
injury.
METHODS: Male Wistar rats were divided into four groups: control-sham, diabetes-sham, myocardial infarction, and
diabetes + myocardial infarction. Myocardial infarction was induced 14 days after diabetes induction. Ventricular
function and morphometry, as well as oxidative stress and hemodynamic parameters, were evaluated after seven
days of myocardial infarction.
RESULTS: The myocardial infarction area, which was similar in the infarcted groups at the initial evaluation, was
reduced in the diabetes + myocardial infarction animals (23¡3%) when compared with the myocardial infarction
(42¡7%, p,0.001) animals at the final evaluation. The ejection fraction (22%, p= 0.003), velocity of circumferential
fiber shortening (30%, p= 0.001), and left ventricular isovolumetric relaxation time (26%, p= 0.002) were increased
in the diabetes + myocardial infarction group compared with the myocardial infarction group. The diabetes-sham
and diabetes + myocardial infarction groups displayed increased catalase concentrations compared to the control-
sham and myocardial infarction groups (diabetes-sham: 32¡3; diabetes + myocardial infarction: 35¡0.7; control-
sham: 12¡2; myocardial infarction: 16¡0.1 pmol min-1 mg-1 protein). The levels of thiobarbituric acid-reactive
substances were reduced in the diabetes-sham rats compared to the control-sham rats. These positive adaptations
were reflected in a reduced mortality rate in the diabetes + myocardial infarction animals (18.5%) compared with
the myocardial infarction animals (40.7%, p= 0.001).
CONCLUSIONS: These data suggest that short-term hyperglycemia initiates compensatory mechanisms, as
demonstrated by increased catalase levels, which culminate in improvements in the ventricular response, infarcted
area, and mortality rate in diabetic rats exposed to ischemic injury.
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INTRODUCTION
The prevalence of diabetes in developed countries is
approaching epidemic proportions, and this disease has
been associated with an increased risk of cardiovascular
abnormalities and microvascular complications.1 In fact,
clinical studies have demonstrated that diabetes, which is
often associated with cardiomyopathy and cardiovascular
neuropathy, is an independent risk factor for cardiovascular
disease, and diabetes is associated with a two- to four-fold
increased risk of coronary heart disease.2
Previous research has demonstrated that hyperglycemia in
diabetic animals leads to changes in the heart that contribute to
injury during and following a myocardial infarction (MI);
however, the response of an uncontrolled hyperglycemic
diabetic heart to ischemic injury remains controversial.3-6
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Experimental studies using an ischemia/reperfusion protocol
have shown that hearts from hyperglycemic rats7 and pigs8
undergoing a period of no-flow ischemia presented a reduced
MI area and better recovery of ventricular function than those
of normoglycemic animals, which indicates a possible
cardioprotective role for hyperglycemic status.
Accordingly, exposure to a high-glucose medium or
diabetes for short periods has been found to protect the
heart against a variety of pathological insults, including
ischemia, hypoxia, and calcium overload.8 A recent study
from our group6 demonstrated that streptozotocin (STZ)-
diabetic rats had a greater plasticity and cellular resistance
to myocardial ischemic injury than nondiabetic rats did, as
demonstrated by a reduced MI area and preserved systolic
function. These results, together with the increased expres-
sion of regulatory genes involved in cardiac cellular
survival and apoptosis, as well as decreased inflammatory
cytokines, further suggest that hyperglycemia may play an
important role after an ischemic event.
Free radical-mediated oxidative stress is intimately
involved in the pathogenesis of heart failure.9 Under
pathological conditions, the delicate balance between free
radical production and the protective antioxidant defense
system may shift to favor a relative increase in free radical-
mediated oxidative stress. An increased level of oxidative
stress has also been shown to accompany a hyperglycemic
diabetic status;10 however, little is known regarding the
oxidative stress that accompanies the experimental diabetes
associated with MI. Therefore, the aim of the present study
was to investigate the effects of hyperglycemia induced by
STZ-induced diabetes on left ventricular dysfunction and
morphometry, MI area, hemodynamic parameters, oxida-
tive stress profile, and mortality rate in rats that had
undergone seven days of MI.
MATERIALS AND METHODS
Experimental Design
Experiments were performed using adult male Wistar
rats (250-270 g) obtained from the animal facility at the
University of Sa˜o Paulo (Sa˜o Paulo, Brazil). The rats were
fed standard laboratory chow and water ad libitum. They
were housed in collective polycarbonate cages in a
temperature-controlled room (22 C˚) with a 12-hour dark-
light cycle (light 07:00-19:00 h). The experimental protocol
was approved by the Institutional Animal Care and Use
Committee of the Medical School of the University of Sa˜o
Paulo, and this investigation was conducted in accordance
with the Guide for the Care and Use of Laboratory Animals
published by the US National Institutes of Health (NIH
Publication No. 85-23, revised 1985). The rats were
randomly assigned to 4 groups: control sham (CS, n = 17),
diabetic sham (DS, n = 17), control infarcted (CI, n = 27), and
diabetes + myocardial infarction (DI, n = 27). Experimental
diabetes was induced by an intravenous injection of 50 mg/
kg STZ (Sigma Chemical Co., St. Louis, MO) dissolved in
citrate buffer (pH 4.2). The rats were fasted overnight before
the STZ injection. The control rats were injected with buffer
only (10 mM citrate buffer, pH 4.5). Forty-eight hours after
the STZ injection, diabetes was confirmed by the measure-
ment of blood glucose levels above 200 mg/dL.
The MI and sham operations were performed in the
respective groups 14 days after the STZ injection according
to the procedures described below. The mortality rate was
investigated during the final seven days of the protocol in
all of the rats (n = 88) beginning after the MI surgery (to
exclude the influence of anesthesia or stress from the
surgical procedure). After MI, the animals, divided into 4
groups (8 animals each), underwent hemodynamic and left
ventricular function evaluations, as well as oxidative stress
analyses.
Myocardial Infarction
Fourteen days after the STZ injection or administration of
the citrate buffer, the rats in the CI and DI groups were
anesthetized (80 mg/kg ketamine and 12 mg/kg xylazine,
administered i.p.) and underwent MI induction by surgical
occlusion of the left coronary artery, as described else-
where.6,11 Briefly, a left thoracotomy was performed, the
third intercostal space was dissected, and the heart was
exposed. The left coronary artery was occluded with a
single nylon (6.0) suture approximately 1 mm distal to the
left atrial appendage. The chest was closed with a silk
suture. The animals were maintained under ventilation until
recovery. The sham rats (CS and DS) underwent the same
procedures except that myocardial ischemia was not
induced.
Left Ventricular Morphometry and Function
Evaluations
Echocardiography was performed seven days after MI
induction or sham operation by a double-blinded observer
according to the guidelines of the American Society of
Echocardiography. The rats were anesthetized (80 mg/kg
ketamine and 12 mg/kg xylazine), and images were obtained
using a 10- to 14-MHz linear transducer in a Sequoia 512
ultrasound system (Acuson Corporation, Mountain View,
CA, USA) for measuring (i) morphometric parameters: left
ventricular mass corrected by body weight (LV mass); left
ventricular end-diastolic diameter (LVEDD); parameters of
systolic function: ejection fraction (EF) and velocity of
circumferential fiber shortening (VCF); (ii) parameters of
diastolic function: left ventricular isovolumetric relaxation
time (IVRT) and peak E deceleration time (EDT); and global
function: myocardial performance index (MPI). The echo-
cardiographic parameters were measured as described in
detail elsewhere.11,12
Hemodynamic Assessment
One day after the final echocardiographic evaluation, two
catheters filled with 0.06 ml of saline were implanted into
the femoral artery of each anesthetized rat (80 mg/kg
ketamine and 12 mg/kg xylazine, i.p.). Twenty-four hours
later, the arterial cannula was connected to a strain-
gauge transducer (Blood Pressure XDCR; Kent Scientific,
Torrington, CT, USA), and arterial pressure (AP) signals
were recorded over a 30-min period in conscious animals
using a microcomputer equipped with an analog-to-digital
converter board (WinDaq, 2 kHz, DATAQ, Springfield, OH,
USA). The recorded data were analyzed on a beat-to-beat
basis to quantify changes in the mean AP (MAP) and heart
rate (HR).11
Catalase and Thiobarbituric Acid-Reactive
Substances Analyses
One day after the hemodynamic evaluations, the animals
were killed by decapitation, the hearts were rapidly
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removed and weighed, and the MI area of the left ventricle
was identified and dissected for analysis. The remainder of
the heart was placed in an ice-cold solution containing
140 mM KCl and 20 mM HEPES (pH 7.4). The hearts were
homogenized using an Ultra Turrax blender and 1 g of
tissue per 5 ml of a 1.15% (w/v)-KCl and 20-mM phenyl-
methylsulfonyl fluoride (PMSF) solution. The homogenates
were then centrifuged at 6006 g for 10 min at 22 C˚ to
remove nuclei and cell debris, as described elsewhere.13 The
supernatants were used for catalase and thiobarbituric acid-
reactive substances (TBARS) assays.
For the TBARS assay, trichloroacetic acid (10%, w/v) was
added to the homogenate to precipitate proteins and to acidify
the samples.14,15 This mixture was then centrifuged (10006g,
3 min), the protein-free sample was extracted, and thiobarbi-
turic acid (0.67%, w/v) was added to the reaction medium.
The tubes were placed in a water bath (100 C˚) for 15 min. The
absorbances were measured at 535 nm using a spectro-
photometer. Commercially available malondialdehyde
(MDA) was used as a standard, and the results are expressed
as nanomoles per milligram of protein.
Catalase (CAT) activity was determined by measuring
the decreased absorbance (240 nm) of hydrogen peroxide
(H2O2). The results are expressed as picomoles of reduced
H2O2 per minute per milligram of protein.
15,16
Myocardial Infarction Size Determinations
Seven days after MI, infarction size was delimited by
subjective identification of the movement of the LV walls by
observing the longitudinal, apical, and transversal echocar-
diographic views of the LV. Regions with a less-than-
normal systolic thickness and portions with paradoxal
movement were considered infarcted. Thus, the infarction
size (%) was determined by the ratio of these regions to the
total perimeter of the LV walls at the initial evaluation (one
day) and seven days after MI surgery.6,11 To confirm the
echocardiography measurement, the MI size was also
evaluated by dissecting the fibrous scar from the remaining
LV muscle. The outlines of both fragments were drawn on
graph paper, and their areas were measured using the cross-
point method17 with the interventricular septum considered
to be part of the left ventricle.
Statistical Analyses
The data are reported as means¡ SEM. After confirming
that all continuous variables were normally distributed using
the Kolmogorov-Smirnov test, statistical differences between
the groups were identified using two-way analysis of
variance (ANOVA) or repeated-measures ANOVA followed
by the Student-Newman-Keuls post-test. Pearson’s correla-
tion was used to study the association between the measured
MI areas. A survival curve was constructed using the Kaplan-
Meier method and the survival curves of the experimental
groups were compared using the log-rank test. All of the tests
were 2-sided, and the significance level was established at
p,0.05. Calculations were performed with Statistical Package
for Social Sciences (SPSS) software, version 12.0.
RESULTS
Animals
The mean body weights were similar among all of the
groups at the beginning of the study (,260¡5 g). As a
result of diabetic induction, the DS (225¡9 g) and DI
(223¡8 g) groups exhibited reduced body weights at the
end of the experimental protocol compared with their initial
values and the final values of the nondiabetic groups (CS:
274¡4 and CI: 252¡9 g). Furthermore, the STZ-diabetic rats
(DS: 290¡27 and DI: 301¡37 mg/dl) had higher plasma
glucose levels compared to the normoglycemic rats (CS:
90¡3 and CI: 96¡3 mg/dl) in all measurements.
LV Morphometry and Function
The echocardiographic parameters of LV morphometry
and function are shown in Table 1. The evaluation
performed seven days after sham or MI surgery revealed
that the LV masses were similar between all the experi-
mental animals; however, an increased LV chamber
(LVEDD) was observed in the MI groups (CI and DI)
compared to the noninfarcted groups (CS and DS). The MI
groups (CI and DI) demonstrated systolic dysfunction, as
evaluated by VCF and EF, compared to the CS and DS
groups. Notably, the DI rats displayed an attenuation of
systolic dysfunction, as demonstrated by increases in EF
and VCF, compared with the CI rats. Similarly, diastolic
function was preserved in the DI animals compared with
the CI animals, as demonstrated by the IVRT echocardio-
graphic parameter. In contrast, no differences in EDT were
observed between the experimental groups. In addition,
the DI group had a reduced MPI compared with the CI
group, which demonstrated a lower level of global
ventricular dysfunction in the diabetic rats after MI
(Table 1).
Hemodynamic Assessments
The hemodynamic evaluation data are listed in Table 2.
The systolic AP was reduced in all of the experimental
groups compared with the CS group; however, the diabetic
groups (DS and DI) displayed additional reductions
compared with the CS and CI groups. Similarly, the DS
and DI groups exhibited diastolic AP and MAP lower than
those of the nondiabetic animals (CS and CI). HR was only
reduced in the DS group compared with the other
experimental groups (Table 2).
Table 1 - Left ventricular morphometry and function one
week after myocardial infarction and three weeks after
STZ-induced diabetes.
Parameters CS DS CI DI
Morphometric
LV mass (g/kg) 1.02¡0.02 0.95¡0.01 1.05¡0.04 1.04¡0.01
LVEDD (cm) 0.65¡0.01 0.63¡0.01 0.75¡0.01*{ 0.77¡0.03*{
Systolic Function
EF (%) 74¡2.1 76¡0.6 44¡2.3*{ 54¡3.2*{{
VCF (circ/s) (10-4) 52¡3 57¡2 30¡2*{ 39¡3*{{
Diastolic Function
IVRT (ms) 33¡2 30¡1 26¡1* 33¡1{
EDT (ms) 1.87¡0.11 1.95¡0.10 1.97¡0.10 1.83¡0.09
Global Function
MPI 0.43¡0.04 0.44¡0.04 0.50¡0.03*{ 0.40¡0.04{
Values are expressed as means ¡ SEM. LV mass – Left ventricular mass
corrected by body weight; LVEDD – Left ventricular end-diastolic
diameter; EF – Ejection fraction; VCF – Velocity of circumferential fiber
shortening; IVRT – Left ventricular isovolumetric relaxation time; EDT –
Peak E desacceleration time; MPI - Myocardial performance index.
*p,0.05 vs. CS;
{p,0.05 vs. DS;
{p,0.05 vs. CI (n = 8 for each group).
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Catalase and TBARS Analyses
The activity of the antioxidant enzyme catalase (CAT),
which catalyzes the reduction of H2O2 to H2O and O2, is
shown in Figure 1A. The diabetic groups (DS and DI)
displayed increased CAT activity in relation to the
nondiabetic groups (CS and CI). The lipoperoxidation
product, as indicated by TBARS analysis, was reduced in
the DS animals compared to the CS, CI, and DI animals.
Surprisingly, no difference was observed between the CI
and DI rats compared to the CS rats (Figure 1B).
Myocardial Infarction Area
The MI area, measured by echocardiography, was similar
between the infarcted groups at the beginning of the protocol
(CI: 40¡3 and DI: 38¡3% of the LV wall). Seven days after
the MI, the infarction size was reduced in the DI animals
(23¡3%) compared to the CI animals (42¡7%). In addition to
echocardiography, the MI size was also evaluated using
millimeter graph paper stamps. Corroborating the echocar-
diographic data, the DI group showed a reduced MI area
(15¡6%) compared to the CI group (37¡5%) and displayed a
positive correlation (r = 0.9, p= 0.0001) between these two MI
size measurements.
Mortality Rate
Figure 2 shows the total mortality rate (Kaplan-Meier
survival curve) for the study groups throughout the seven-
day experimental period. During the seven days after sham
or MI surgery, the total mortality was similar between the
CS (no deaths) and DS (1 death among 17 DS rats, 5.8%)
animals. However, the mortality rate was higher (p,0.003)
for the CI and DI rats compared with the CS and DS rats.
Notably, the DI group (5 deaths among 27 DI rats, 18.5%)
had a reduced mortality rate compared with the CI group
(11 deaths among 27 rats, 40.7%; Figure 2).
DISCUSSION
The key finding of the present investigation is that the left
ventricular dysfunction induced by MI was attenuated in
diabetic rats, which is an attenuation that may be associated
with the reduced myocardial infarction area and the
increased concentration of catalase, an important antiox-
idant enzyme, observed in these animals. Furthermore,
these positive adaptations were reflected in a reduction
in the mortality rate in the diabetic rats following MI
compared with the nondiabetic rats.
Evidence has been accumulating from clinical studies
with diabetic patients that an increased risk of MI and a
higher rate of mortality exists in these individuals. Although
it has been acknowledged that intensively controlling
glucose levels in patients with diabetes reduces the risk of
vascular complications, the evidence supporting the role of
glycemic control in reducing cardiovascular risk is more
limited. Several prospective intervention studies published
in the past two years have investigated whether intensive
glucose control to near normoglycemia reduces cardiovas-
cular events and mortality in individuals with diabetes.
Table 2 - Hemodynamic parameters in control sham (CS),
diabetic sham (DS), control infarcted (CI), and diabetic
infarcted (DI) groups.
CS DS CI DI p-values
SAP (mm Hg) 128¡2 109¡3* 117¡3*{ 106¡2*{ ,0.0001
DAP (mm Hg) 93¡2 83¡3* 90¡3 84¡2* 0.003
MAP (mm Hg) 110¡8 96¡3* 104¡2 98¡2* 0.005
HR (bpm) 364¡12 302¡8* 367¡6{ 366¡10{ 0.002
Values are expressed as the means¡ SEM. SAP – Systolic arterial pressure;
DAP – Diastolic arterial pressure; MAP – Mean arterial pressure; HR – Heart
rate.
*p,0.05 vs. CS;
{p,0.05 vs. DS;
{p,0.05 vs. CI (n = 8 for each group).
Figure 1 - Oxidative profiles of cardiac homogenates in control
sham (CS), diabetes sham (DS), myocardial infarction (CI), and
diabetes + myocardial infarction (DI) rats (n = 8 for each group).
A: Catalase activity. B: Lipid peroxidation indicated by thiobar-
bituric acid-reactive substances (TBARS). * p,0.05 vs. CS;
{ p,0.05 vs. DS; { p,0.05 vs. CI.
Figure 2 - Mortality rates, as estimated by Kaplan-Meier survival
curves for the control sham (CS), diabetes sham (DS), myocardial
infarction (CI), and diabetes + myocardial infarction (DI) rats.
* p,0.05 vs. CS; { p,0.05 vs. DS; { p,0.05 vs. CI.
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These studies have produced conflicting results, where the
use of intensive therapy to target normal glycated hemoglo-
bin levels increased mortality and did not significantly
reduce major cardiovascular events.18-20
In this sense, conflicting data have also been observed,
mainly in experimental studies, and a greater resistance of
hyperglycemic diabetic animals to ischemic injury has been
demonstrated.6-8 Previous reports have shown that glucose
supply plays a critical cardioprotective role in cardiac
responses during acute ischemia. These findings suggest
that a higher rate of glucose delivery to the heart may
improve tolerance to ischemic stress and may lead to
changes in the signaling mechanisms involved in cardio-
protection.21,22 However, these protective alterations may be
eliminated by preoperative treatment with insulin.23 To
further investigate the mechanisms underlying the
improved tolerance to ischemia in STZ-diabetic rats, we
evaluated cardiac morphometry and function in the experi-
mental groups.
Myocardial remodeling after MI is typically characterized
by compensatory hypertrophy of myocytes, ventricular
dilatation, and increased interstitial collagen deposition.5
In our study, LVEDD was increased in the infarcted groups
compared with the noninfarcted groups; however, the CI
and DI groups had similar LV mass and LVEDD values,
which highlights the lack of influence of STZ-induced
diabetes on cardiac remodeling after MI in this study.
In regard to cardiac function, although a reduction in SAP
was observed in the DI group compared with the CI group,
our data indicate that diabetes partially attenuated the
ventricular dysfunction caused by myocardial ischemia (DI
animals compared with CI animals). In fact, the DI animals
displayed improvements in systolic (EF and VCF) and
diastolic (IVRT) function indices compared to the CI
animals. Along with reduced MPI, increases in these indices
indicate global myocardial stress.12 These data corroborate
previous findings from our group, which showed that, 15
days after MI, STZ-diabetic rats exhibited an attenuation of
cardiac dysfunction, as evaluated by echocardiography,
compared with normoglycemic rats.6 Notably, this attenua-
tion was associated with improved net balances of inflam-
matory cytokines and regulatory genes that participate in
cardiac cellular survival.6
Recently, Chu et al.8 provided evidence that diabetes
induced by aloxan, which results in hyperglycemia, was
protective against myocardial ischemic-reperfusion injury
in pigs in the short term. The researchers observed
pronounced reductions in MI area in diabetic animals,
which was associated with the expression of cell survival
proteins, including phosphorylated endothelial nitric oxide
synthase and heat shock protein-27. Similarly, in the present
investigation, the DI rats exhibited reductions in MI area
compared with the CI rats, which was determined using
echocardiography and was confirmed using millimeter
graph paper stamps. These data are similar to previous
findings from our group6 and may explain the attenuated
cardiac dysfunction observed in diabetic animals.
Some studies have demonstrated that a reduction in MI
size6,8,24 may be caused by the diminished number of dead
myocytes in diabetic animals;25 increased capillary density;
and the expression of cardioprotective proteins, including
vascular endothelial growth factor, eNOS, and phospho-
Akt23 and would thus be instrumental in the higher
resistance of diabetic rats to ischemic injury.
In diabetes or after myocardial infarction, the augmented
production of reactive oxygen species such as superoxide
(O2-), hydroxyl (OH) and non-radicals capable of generat-
ing free radicals (eg, hydrogen peroxide (H2O2), leads to
reductions of most antioxidant defenses9,15 and macromo-
lecule damage. These reactive oxygen species participate in
some intracellular pathways, such as the activation of
various mitogen activated protein kinases, increased activa-
tion of NF-KB, disruption of calcium cycling, alteration of
myofilament responsiveness to the calcium, expression of
pro-fibrotic growth factors, and inflammatory cell infiltra-
tion, lading to cardiomyocyte hypertrophy, apoptosis,
interstitial fibrosis, and consequently LV dysfunction.26-28
The increased TBARS levels observed in the CI group are
in agreement with findings from previous studies.9
However, the DS group exhibited a reduction in TBARS
levels compared to the controls. This result may be
attributed to short-term exposure to diabetes or even to
the increased concentration of CAT observed in the DS and
DI groups. In fact, the increased CAT activity in the LV of
the diabetic groups may have blocked one pathway of lipid
peroxidation, which is a mechanism likely to explain the
reduced TBARS levels in these animals.29 CAT activity in
the heart peroxisomes of diabetic rats may be increased in
response to the augmented formation of H2O2, a subproduct
of the enzymatic activity of acyl-CoA oxidase that initiates
the ß-oxidation of fatty acids in peroxisomes.15,30 Therefore,
the reduced MI area and attenuated LV dysfunction
observed in DI rats may be explained, at least in part, by
the increase in CAT levels.
In conclusion, in the present investigation, we demon-
strated that the MI area and left ventricular dysfunction in
diabetic animals were attenuated after seven days of MI.
These findings are probably caused by compensatory
mechanisms associated with metabolic and molecular
adjustments of cardiac tissue, particularly the increased
level of catalase. Furthermore, these compensatory
mechanisms culminated in a reduction in the mortality
rate of DI animals compared to CI animals. These data
suggest that short-term hyperglycemia may protect the
heart against an ischemic insult and thus reduce the
mortality rate and preserve ventricular function. It is
important to emphasize that, in the present investigation,
the time courses of diabetes and MI were predetermined, in
contrast to what occurs in clinical situations. Therefore, it is
possible that this improved cardiac function is transitory
and that cardiovascular autonomic dysfunction (not eval-
uated in the present study) may lead to cardiovascular
damage in the long term, as observed in diabetic patients
following an ischemic event.
Study Limitations
Some possible limitations of the present investigation
deserve comment. First, because the LV was only evaluated
at the end of the protocol and necropsies were not
performed on the animals that died during the seven days
of the protocol, it may be difficult to predict survival
outcomes (or mortality) based on these parameters. Second,
in the present study, we only evaluated a small sample of
anti- and pro-oxidant products; however, these evaluations
may provide a general concept of the profile of oxidative
stress in diabetic rats, infarcted or not.
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